{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:33:25Z","timestamp":1779309205842,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The leishmanin skin test was used for almost a century to detect exposure and immunity to <jats:italic>Leishmania<\/jats:italic>, the causative agent of leishmaniasis, a major neglected tropical disease. Due to a lack of antigen used for the intradermal injection, the leishmanin skin test is no longer available. As leishmaniasis control programs are advancing and new vaccines are entering clinical trials, it is essential to re-introduce the leishmanin skin test. Here we establish a <jats:italic>Leishmania donovani<\/jats:italic> strain and describe the production, under Good Laboratory Practice conditions, of leishmanin soluble antigen used to induce the leishmanin skin test in animal models of infection and vaccination. Using a mouse model of cutaneous leishmaniasis and a hamster model of visceral leishmaniasis, soluble antigen induces a leishmanin skin test response following infection and vaccination with live attenuated <jats:italic>Leishmania major<\/jats:italic> (<jats:italic>LmCen<\/jats:italic><jats:sup><jats:italic>-\/-<\/jats:italic><\/jats:sup>). Both the CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T-cells are necessary for the leishmanin skin test response. This study demonstrates the feasibility of large-scale production of leishmanin antigen addressing a major bottleneck for performing the leishmanin skin test in future surveillance and vaccine clinical trials.<\/jats:p>","DOI":"10.1038\/s41467-023-42732-2","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T18:02:55Z","timestamp":1698948175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Production of leishmanin skin test antigen from Leishmania donovani for future reintroduction in the field"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0069-7867","authenticated-orcid":false,"given":"Ranadhir","family":"Dey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jalal","family":"Alshaweesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamaleshwar P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5550-712X","authenticated-orcid":false,"given":"Patrick","family":"Lypaczewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subir","family":"Karmakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Klenow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9379-9509","authenticated-orcid":false,"given":"Kayla","family":"Paulini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swarnendu","family":"Kaviraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4304-636X","authenticated-orcid":false,"given":"Shaden","family":"Kamhawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5589-9450","authenticated-orcid":false,"given":"Jesus G.","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3881-8337","authenticated-orcid":false,"given":"Shinjiro","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5989-1520","authenticated-orcid":false,"given":"Abhay R.","family":"Satoskar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6557-8220","authenticated-orcid":false,"given":"Sreenivas","family":"Gannavaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4941-1620","authenticated-orcid":false,"given":"Hira L.","family":"Nakhasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8971-5525","authenticated-orcid":false,"given":"Greg","family":"Matlashewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"42732_CR1","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","volume":"392","author":"S Burza","year":"2018","unstructured":"Burza, S., Croft, S. L. & Boelaert, M. Leishmaniasis. Lancet 392, 951\u2013970 (2018).","journal-title":"Lancet"},{"key":"42732_CR2","doi-asserted-by":"publisher","unstructured":"Alves, F. et al. Recent development of visceral leishmaniasis treatments: Successes, pitfalls, and perspectives. Clin. Microbiol. Rev. https:\/\/doi.org\/10.1128\/cmr.00048-18 (2018).","DOI":"10.1128\/cmr.00048-18"},{"key":"42732_CR3","first-page":"k5224","volume":"364","author":"S Rijal","year":"2019","unstructured":"Rijal, S. et al. Eliminating visceral leishmaniasis in South Asia: the road ahead. BMJ (Online) 364, k5224 (2019).","journal-title":"BMJ (Online)"},{"key":"42732_CR4","doi-asserted-by":"publisher","unstructured":"Cloots, K. et al. Impact of the visceral leishmaniasis elimination initiative on Leishmania donovani transmission in Nepal: a 10-year repeat survey. Lancet Glob. Heal. https:\/\/doi.org\/10.1016\/S2214-109X(19)30536-4 (2020).","DOI":"10.1016\/S2214-109X(19)30536-4"},{"key":"42732_CR5","doi-asserted-by":"publisher","unstructured":"Volpedo, G. et al. From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection. Expert Rev. Vaccines https:\/\/doi.org\/10.1080\/14760584.2021.1969231 (2021).","DOI":"10.1080\/14760584.2021.1969231"},{"key":"42732_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17154-z","volume":"11","author":"WW Zhang","year":"2020","unstructured":"Zhang, W. W. et al. A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing. Nat. Commun. 11, 3461 (2020).","journal-title":"Nat. Commun."},{"key":"42732_CR7","doi-asserted-by":"publisher","unstructured":"Osman, M. et al. A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: first-in-human trial of ChAd63-KH. PLoS Negl. Trop. Dis. https:\/\/doi.org\/10.1371\/journal.pntd.0005527 (2017).","DOI":"10.1371\/journal.pntd.0005527"},{"key":"42732_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20569-3","volume":"12","author":"H Ashwin","year":"2021","unstructured":"Ashwin, H. et al. Characterization of a new Leishmania major strain for use in a controlled human infection model. Nat. Commun. 12, 215 (2021).","journal-title":"Nat. Commun."},{"key":"42732_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1001\/archderm.1926.02370140053003","volume":"13","author":"J Montenegro","year":"1926","unstructured":"Montenegro, J. Cutaneous reaction in leishmaniasis. Arch. Derm. Syphilol. 13, 187\u2013194 (1926).","journal-title":"Arch. Derm. Syphilol."},{"key":"42732_CR10","doi-asserted-by":"publisher","unstructured":"Carstens-Kass, J., Paulini, K., Lypaczewski, P. & Matlashewski, G. A review of the leishmanin skin test: a neglected test for a neglected disease. PLoS Negl. Trop. Dis. https:\/\/doi.org\/10.1371\/journal.pntd.0009531 (2021).","DOI":"10.1371\/journal.pntd.0009531"},{"key":"42732_CR11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1056\/NEJM197509042931013","volume":"293","author":"JE Sokal","year":"1975","unstructured":"Sokal, J. E. Measurement of delayed skin-test responses. N. Engl. J. Med. 293, 501\u2013502 (1975).","journal-title":"N. Engl. J. Med."},{"key":"42732_CR12","doi-asserted-by":"publisher","unstructured":"Skraba, C. M. et al. Evaluation of the reference value for the Montenegro skin test. Rev. Soc. Bras. Med. Trop. https:\/\/doi.org\/10.1590\/0037-8682-0067-2015 (2015).","DOI":"10.1590\/0037-8682-0067-2015"},{"key":"42732_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/BST20200606","volume":"49","author":"T Pacheco-Fernandez","year":"2021","unstructured":"Pacheco-Fernandez, T., Volpedo, G., Verma, C. & Satoskar, A. R. Understanding the immune responses involved in mediating protection or immunopathology during leishmaniasis. Biochem. Soc. Trans. 49, 297\u2013311 (2021).","journal-title":"Biochem. Soc. Trans."},{"key":"42732_CR14","doi-asserted-by":"publisher","first-page":"744","DOI":"10.4269\/ajtmh.2006.75.744","volume":"75","author":"C Bern","year":"2006","unstructured":"Bern, C. et al. Loss of leishmanin skin test antigen sensitivity and potency in a longitudinal study of visceral leishmaniasis in Bangladesh. Am J Trop Med Hyg. 75, 744\u20138 (2006).","journal-title":"Am J Trop Med Hyg."},{"key":"42732_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1046\/j.1365-3156.2002.00832.x","volume":"7","author":"EAG Khalil","year":"2002","unstructured":"Khalil, E. A. G., Zijlstra, E. E., Kager, P. A. & El Hassan, A. M. Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan. Trop. Med. Int. Heal. 7, 35\u201344 (2002).","journal-title":"Trop. Med. Int. Heal."},{"key":"42732_CR16","doi-asserted-by":"publisher","first-page":"826","DOI":"10.4269\/ajtmh.1994.51.826","volume":"51","author":"EE Zijlstra","year":"1994","unstructured":"Zijlstra, E. E., El-Hassan, A. M., Ismael, A. & Ghalib, H. W. Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. Am. J. Trop. Med. Hyg. 51, 826\u2013836 (1994).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"42732_CR17","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/intimm\/3.6.587","volume":"3","author":"I M\u00fcller","year":"1991","unstructured":"M\u00fcller, I., Pedrazzini, T., Kropf, P., Louis, J. & Milon, G. Establishment of resistance to Leishmania major infection in susceptible BALB\/c mice requires parasite-specific CD8+ T cells. Int. Immunol. 3, 587\u2013597 (1991).","journal-title":"Int. Immunol."},{"key":"42732_CR18","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1002\/eji.1830221206","volume":"22","author":"I M\u00fcller","year":"1992","unstructured":"M\u00fcller, I. Role of T cell subsets during the recall of immunologic memory to Leishmania major. Eur. J. Immunol. 22, 3063\u20133069 (1992).","journal-title":"Eur. J. Immunol."},{"key":"42732_CR19","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nri933","volume":"2","author":"D Sacks","year":"2002","unstructured":"Sacks, D. & Noben-Trauth, N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2, 845\u2013858 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"42732_CR20","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/infdis\/jis932","volume":"207","author":"H Aslan","year":"2013","unstructured":"Aslan, H. et al. A new model of progressive visceral leishmaniasis in hamsters by natural transmission via bites of vector sand flies. J. Infect. Dis. 207, 1328\u20131338 (2013).","journal-title":"J. Infect. Dis."},{"key":"42732_CR21","doi-asserted-by":"publisher","first-page":"e250","DOI":"10.1016\/S2666-5247(21)00028-8","volume":"2","author":"P Lypaczewski","year":"2021","unstructured":"Lypaczewski, P. & Matlashewski, G. Leishmania donovani hybridisation and introgression in nature: a comparative genomic investigation. Lancet Microbe 2, e250\u2013e258 (2021).","journal-title":"Lancet Microbe"},{"key":"42732_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34812-x","volume":"8","author":"P Lypaczewski","year":"2018","unstructured":"Lypaczewski, P. et al. A complete Leishmania donovani reference genome identifies novel genetic variations associated with virulence. Sci. Rep. 8, 16549 (2018).","journal-title":"Sci. Rep."},{"key":"42732_CR23","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/s42003-021-02446-x","volume":"4","author":"S Karmakar","year":"2021","unstructured":"Karmakar, S. et al. Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis. Commun. Biol. 4, 929 (2021).","journal-title":"Commun. Biol."},{"key":"42732_CR24","doi-asserted-by":"publisher","unstructured":"Ordeix, L. et al. Histological and Immunological Description of the Leishmanin Skin Test in Ibizan Hounds. J. Comp. Pathol. https:\/\/doi.org\/10.1016\/j.jcpa.2017.11.004 (2018).","DOI":"10.1016\/j.jcpa.2017.11.004"},{"key":"42732_CR25","doi-asserted-by":"publisher","unstructured":"Guar\u00edn, N. et al. Comparative immunohistological analysis of the Montenegro skin test reaction in asymptomatic infection and in acute and chronic cutaneous leishmaniasis. Biomedica https:\/\/doi.org\/10.7705\/biomedica.v26i1.1498 (2006).","DOI":"10.7705\/biomedica.v26i1.1498"},{"key":"42732_CR26","doi-asserted-by":"publisher","unstructured":"Bousoffara, T., Louzir, H., Ben Salah, A. & Dellagi, K. Analysis of granzyme B activity as a surrogate marker of Leishmania-specific cell-mediated cytotoxicity in zoonotic cutaneous leishmaniasis. J. Infect. Dis. https:\/\/doi.org\/10.1086\/382031 (2004).","DOI":"10.1086\/382031"},{"key":"42732_CR27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/0035-9203(93)90083-3","volume":"87","author":"MH Alimohammadian","year":"1993","unstructured":"Alimohammadian, M. H., Kivanjah, M., Pak, F., Gaznavia, A. & Kharazmi, A. Evaluation of the efficacy of Iran leishmanin and comparison with leishmanins from Wellcome (UK) and Roma (Italy) in cured cutaneous leishmaniasis patients. Trans. R. Soc. Trop. Med. Hyg. 87, 550\u2013551 (1993).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"42732_CR28","unstructured":"Organization, W. H. Tropical disease research: progress 1975-94: Highlights 1993-94, twelfth programme report. In: Tropical Disease Research: Progress 1975-94: Highlights 1993-94, Twelfth Programme Report 168 (1995)."},{"key":"42732_CR29","doi-asserted-by":"publisher","unstructured":"Chapman, L. A. C. et al. Age trends in asymptomatic and symptomatic Leishmania donovani infection in the Indian subcontinent: a review and analysis of data from diagnostic and epidemiological studies. PLoS Negl. Trop. Dis. https:\/\/doi.org\/10.1371\/journal.pntd.0006803 (2018).","DOI":"10.1371\/journal.pntd.0006803"},{"key":"42732_CR30","doi-asserted-by":"publisher","unstructured":"Yangzom, T. et al. Endemic transmission of visceral leishmaniasis in Bhutan. Am. J. Trop. Med. Hyg. https:\/\/doi.org\/10.4269\/ajtmh.2012.12-0211 (2012).","DOI":"10.4269\/ajtmh.2012.12-0211"},{"key":"42732_CR31","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(00)03128-7","volume":"356","author":"EAG Khalil","year":"2000","unstructured":"Khalil, E. A. G. et al. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan. Lancet 356, 1565\u20131569 (2000).","journal-title":"Lancet"},{"key":"42732_CR32","doi-asserted-by":"publisher","unstructured":"Mayrink, W. et al. A field trial of a vaccine against american dermal leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. https:\/\/doi.org\/10.1016\/0035-9203(79)90159-7 (1979).","DOI":"10.1016\/0035-9203(79)90159-7"},{"key":"42732_CR33","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkp851","volume":"38","author":"M Aslett","year":"2009","unstructured":"Aslett, M. et al. TriTrypDB: a functional genomic resource for the Trypanosomatidae. Nucleic Acids Res. 38, D457\u201362 (2009).","journal-title":"Nucleic Acids Res."},{"key":"42732_CR34","unstructured":"Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. https:\/\/arxiv.org\/abs\/1303.3997 (2013)."},{"key":"42732_CR35","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"42732_CR36","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt, D. C. et al. VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568\u2013576 (2012).","journal-title":"Genome Res."},{"key":"42732_CR37","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1101\/gr.092759.109","volume":"19","author":"M Krzywinski","year":"2009","unstructured":"Krzywinski, M. et al. Circos: an information aesthetic for comparative genomics. Genome Res. 19, 1639\u20131645 (2009).","journal-title":"Genome Res."},{"key":"42732_CR38","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1093\/bioinformatics\/btx100","volume":"33","author":"P Danecek","year":"2017","unstructured":"Danecek, P. & McCarthy, S. A. BCFtools\/csq: Haplotype-aware variant consequences. Bioinformatics 33, 2037\u20132039 (2017).","journal-title":"Bioinformatics"},{"key":"42732_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4269\/ajtmh.1986.35.79","volume":"35","author":"SG Reed","year":"1986","unstructured":"Reed, S. G. et al. Selection of a skin test antigen for American visceral leishmaniasis. Am J Trop Med Hyg. 35, 79\u201385 (1986).","journal-title":"Am J Trop Med Hyg."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42732-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42732-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42732-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T06:02:06Z","timestamp":1698991326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42732-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["42732"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-42732-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"26 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: The FDA is currently a co-owner of two US patents that claim attenuated Leishmania species with the Centrin gene deletion (US7,887,812 and US 8,877,213). K.P.S., Subir Karmakar, Swarnendu Kaviraj and S.S. are employees of Gennova Biopharmaceuticals. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7028"}}